MARKET

HURA

HURA

TuHURA Biosciences
NASDAQ
0.6290
+0.1890
+42.95%
After Hours: 0.5803 -0.0487 -7.74% 19:30 02/06 EST
OPEN
0.4279
PREV CLOSE
0.4400
HIGH
0.6450
LOW
0.4268
VOLUME
2.31M
TURNOVER
--
52 WEEK HIGH
5.03
52 WEEK LOW
0.4100
MARKET CAP
38.19M
P/E (TTM)
-0.3920
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 1d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/6/26
TipRanks · 1d ago
VOO vs. VTI vs. VTWO: Which Vanguard ETF Offers the Best Upside in 2026?
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/4/26
TipRanks · 3d ago
TuHURA Biosciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Reiterates Buy on TuHURA Biosciences, Maintains $10 Price Target
Benzinga · 4d ago
More
About HURA
TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. Its lead innate immune agonist, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It has initiated a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) compared to Keytruda plus placebo in first-line treatment for advanced or metastatic Merkel Cell Carcinoma. It is leveraging its Delta Opioid Receptor technology to develop bi-specific antibody drug conjugates and antibody peptide conjugates targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. It is also focused on the novel VISTA inhibiting mAb, known as TBS-2025.

Webull offers TuHURA Biosciences Inc stock information, including NASDAQ: HURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HURA stock methods without spending real money on the virtual paper trading platform.